The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / T•••••• D••••••

DCP Announces Strategic Investment in T•••••• D••••••, A Leading Diabetes Pharmaceutical Company in China DCP, a leading international private equity firm, announced that it has reached an agreement to acqu...

Growth investmentannouncedannounced Sep 11, 2020Fact
What happened
Target
T•••••• D••••••
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
healthcare / healthcare, pharma
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
$283M (disclosed by a party)
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
  • D•••• L••Deal partnerconfirmed
    “"DCP is very excited to become a strategic partner of T•••••• D••••••," said D•••• L••, Executive Chairman of DCP.”
  • W•••• W•••Deal partnerconfirmed
    “We are deeply impressed by T•••••• D••••••'s outstanding management team and look forward to working with them on the value creation ahead." said W•••• W•••, Managing Director of DCP.”
  • D••Sponsorconfirmed
    “DCP, a leading international private equity firm, announced that it has reached an agreement to acquire a 9% stake in A-share listed T•••••• D•••••• Pharmaceutical Co., Ltd. ("T•••••• D••••••" or "Company") from D•••••• Industrial Group Limited ("D•••••• Group"), for a consideration of approximately”
Side not stated
  • C•••••••• L•••Managementconfirmed
    “C•••••••• L•••, Chairman and CEO of T•••••• D•••••• said: "We are excited to have DCP as our strategic investor.”
  • T•••••• D••••••Targetconfirmed
    “DCP Announces Strategic Investment in T•••••• D••••••, A Leading Diabetes Pharmaceutical Company in China DCP, a leading international private equity firm, announced that it has reached an agreement to acqu...”
Evidence
“DCP Announces Strategic Investment in T•••••• D••••••, A Leading Diabetes Pharmaceutical Company in China DCP, a leading international private equity firm, announced that it has reached an agreement to acqu...”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
DCP Announces Strategic Investment in T•••••• D••••••, A Leading Diabetes Pharmaceutical C | Private Equity Intelligence | DFX